Experiences with Simplera sync™ all‐in‐one sensors and extended wear infusion sets in adolescents and young adults using the MiniMed ™ 780G : A qualitative study
Authors' conclusion
The transition from Guardian™ 4 and 3-day infusion sets to Simplera Sync™ and EIS was overall positive, with participants reporting enhanced user experience, greater convenience, and improved autonomy. However, challenges with premature sensor failure and alarm functionality were identified at times. These findings highlight the importance of continued technological advancement while maintaining multiple options to accommodate individual needs and preferences.
Study context
- Population
- Young people (7–25 years) with T1D and previously very elevated glycaemia (≥69 mmol/mol) using the MiniMed 780G advanced hybrid closed-loop (AHCL) system; used the upgraded system for at least 4 weeksCO-PILOT extension phase
- Participants
- 11 people
- Comparison
- Transition from MiniMed 780G AHCL with Guardian 4 CGM and 3-day infusion sets to Simplera Sync all-in-one CGM and 7-day EIS
- Outcome
- User experience of the technology transition
Methodological detailssemi-structured interviews, thematic analysis, CO-PILOT trial extension phase
- Semi-structured interviews
- Thematic analysis
- CO-PILOT trial extension phase
Main finding
As reported in the abstract
- Burden-reducing aspects: easier, independent insertion of sensors and infusion sets; improved device design (slimmer profile, one-piece disposable); fewer equipment changes; decreased psychosocial burden
- Ongoing burden: premature sensor failures, pump–sensor connection issues, adhesion problems, concerns about alarm functionality
- Trust in the AHCL system remained high across both systems for most participants
Original publication
Experiences with Simplera sync™ all‐in‐one sensors and extended wear infusion sets in adolescents and young adults using the MiniMed ™ 780G : A qualitative study. Diabet Med. Published 29 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →